Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2019

01-04-2019 | Images

Leg Type Primary Cutaneous Diffuse Large B-Cell Lymphoma

Authors: Giovanni D’Arena, Giovanna Galdo, Vittoria Lalinga, Antonella Miraglia, Giuseppe Pietrantuono, Pellegrino Musto, Giulia Vita

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2019

Login to get access

Excerpt

A 78-year old woman presented with a 3-months history of gradually and rapidly expanding slightly tender, erythematous, focally indurated plaques with irregular borders on the posterior aspect of her right lower leg (Fig. 1). No palpable enlarged lymph node was also found.
Literature
1.
go back to reference Maijer CJLM, Vergier B, Duncan LM, Willemze R (2008) Primary cutaneous DLBCL, leg type. In: Swerdlow SH, Campo E, Harril NL, et al. (eds) WHO classification of tumours of hematopoietic and lymphoid tissue. Lyon, p 242 Maijer CJLM, Vergier B, Duncan LM, Willemze R (2008) Primary cutaneous DLBCL, leg type. In: Swerdlow SH, Campo E, Harril NL, et al. (eds) WHO classification of tumours of hematopoietic and lymphoid tissue. Lyon, p 242
2.
go back to reference Wilcox RA (2015) Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management. Am J Hematol 90:74–76CrossRef Wilcox RA (2015) Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management. Am J Hematol 90:74–76CrossRef
Metadata
Title
Leg Type Primary Cutaneous Diffuse Large B-Cell Lymphoma
Authors
Giovanni D’Arena
Giovanna Galdo
Vittoria Lalinga
Antonella Miraglia
Giuseppe Pietrantuono
Pellegrino Musto
Giulia Vita
Publication date
01-04-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-1036-8

Other articles of this Issue 2/2019

Indian Journal of Hematology and Blood Transfusion 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine